Haemonetics Vascular Closure

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Haemonetics

Fresenius Kabi is a global healthcare company that specializes in medical devices and pharmaceutical products, including blood collection and processing systems.

Fresenius Kabi

Terumo BCT, Inc. is a leading global medical device company that specializes in blood component, therapeutic apheresis, and cellular technologies.

Terumo BCT, Inc.

BD is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.

BD (Becton, Dickinson and Company)

Abbott Laboratories is a multinational healthcare company that focuses on the development and manufacture of various healthcare products, including medical devices and diagnostics.

Abbott Laboratories Inc.

Medtronic is a global healthcare solutions company that specializes in medical devices, therapies, and services.

Medtronic, Inc.

Haemonetics Corporation is a global healthcare company that specializes in blood management solutions. The company focuses on providing innovative medical devices and software solutions for blood and plasma collection, as well as blood processing and transfusion services. Haemonetics aims to improve the quality and safety of the blood supply, enhance clinical outcomes, and reduce healthcare costs.

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Haemonetics Corporation

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 5:44 AM	e1499605
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	46cb946c
crunchbase profile	general
li profile	general	May 16, 2024 5:44 AM	1f183658
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:HAEMONETICS

Haemonetics Corporation

Last Close

85.43

22/11 21:00

Market Cap

4.44B

Beta: -

Volume Today

481.00K

Avg: -